Safety & Pharmacokinetics of Pegolsihematide for Treatment of Anemia Patient With Myelodysplastic Syndromes

Clinical trial NCT02619097 · UNKNOWN

Trial details

NCT number: NCT02619097
Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Anemia

Start date: 2014-06-01
Primary completion: 2015-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.